Overview

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare cisplatin-based with carboplatin-based chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of carboplatin-based chemoradiotherapy in NPC patients.
Phase:
Phase 3
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Treatments:
Carboplatin
Cisplatin
Docetaxel